Bristol Myers Acquire Karuna Therapeutics in $14 Billion Megadeal

Bristol Myers Acquire Karuna Therapeutics in $14 Billion Megadeal

In a strategic move, Bristol Myers Squibb has announced a groundbreaking acquisition of Karuna Therapeutics for a staggering $14 billion,…